1. Home
  2. TKNO vs TACH Comparison

TKNO vs TACH Comparison

Compare TKNO & TACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • TACH
  • Stock Information
  • Founded
  • TKNO 1996
  • TACH 2024
  • Country
  • TKNO United States
  • TACH United States
  • Employees
  • TKNO N/A
  • TACH N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • TACH
  • Sector
  • TKNO Health Care
  • TACH
  • Exchange
  • TKNO Nasdaq
  • TACH Nasdaq
  • Market Cap
  • TKNO 340.9M
  • TACH 349.1M
  • IPO Year
  • TKNO 2021
  • TACH 2025
  • Fundamental
  • Price
  • TKNO $5.33
  • TACH N/A
  • Analyst Decision
  • TKNO
  • TACH
  • Analyst Count
  • TKNO 0
  • TACH 0
  • Target Price
  • TKNO N/A
  • TACH N/A
  • AVG Volume (30 Days)
  • TKNO 370.4K
  • TACH 93.4K
  • Earning Date
  • TKNO 11-06-2025
  • TACH 01-01-0001
  • Dividend Yield
  • TKNO N/A
  • TACH N/A
  • EPS Growth
  • TKNO N/A
  • TACH N/A
  • EPS
  • TKNO N/A
  • TACH 0.19
  • Revenue
  • TKNO $38,923,000.00
  • TACH N/A
  • Revenue This Year
  • TKNO $9.52
  • TACH N/A
  • Revenue Next Year
  • TKNO $15.20
  • TACH N/A
  • P/E Ratio
  • TKNO N/A
  • TACH $53.19
  • Revenue Growth
  • TKNO 11.40
  • TACH N/A
  • 52 Week Low
  • TKNO $3.94
  • TACH $10.00
  • 52 Week High
  • TKNO $10.37
  • TACH $10.38
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 51.65
  • TACH N/A
  • Support Level
  • TKNO $5.20
  • TACH N/A
  • Resistance Level
  • TKNO $6.68
  • TACH N/A
  • Average True Range (ATR)
  • TKNO 0.61
  • TACH 0.00
  • MACD
  • TKNO -0.04
  • TACH 0.00
  • Stochastic Oscillator
  • TKNO 36.29
  • TACH 0.00

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About TACH Titan Acquisition Corp. Class A Ordinary Shares

Titan Acquisition Corp is a blank check company.

Share on Social Networks: